369 related articles for article (PubMed ID: 26328490)
1. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
Parajuli P; Tiwari RV; Sylvester PW
Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
[TBL] [Abstract][Full Text] [Related]
2. Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells.
Parajuli P; Tiwari RV; Sylvester PW
Cell Prolif; 2015 Aug; 48(4):421-35. PubMed ID: 26096843
[TBL] [Abstract][Full Text] [Related]
3. γ-Tocotrienol Suppression of the Warburg Effect Is Mediated by AMPK Activation in Human Breast Cancer Cells.
Dronamraju V; Ibrahim BA; Briski KP; Sylvester PW
Nutr Cancer; 2019; 71(7):1214-1228. PubMed ID: 30955359
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
5. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity.
Shah SJ; Sylvester PW
Exp Biol Med (Maywood); 2005 Apr; 230(4):235-41. PubMed ID: 15792944
[TBL] [Abstract][Full Text] [Related]
6. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment.
Akl MR; Ayoub NM; Sylvester PW
Planta Med; 2012 Nov; 78(16):1731-9. PubMed ID: 22987298
[TBL] [Abstract][Full Text] [Related]
8. γ-Tocotrienol-induced autophagy in malignant mammary cancer cells.
Tiwari RV; Parajuli P; Sylvester PW
Exp Biol Med (Maywood); 2014 Jan; 239(1):33-44. PubMed ID: 24231340
[TBL] [Abstract][Full Text] [Related]
9. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells.
Samant GV; Sylvester PW
Cell Prolif; 2006 Dec; 39(6):563-74. PubMed ID: 17109639
[TBL] [Abstract][Full Text] [Related]
10. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway.
Zhang X; Ai Z; Chen J; Yi J; Liu Z; Zhao H; Wei H
Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993
[TBL] [Abstract][Full Text] [Related]
11. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells.
Wali VB; Sylvester PW
Lipids; 2007 Dec; 42(12):1113-23. PubMed ID: 17701065
[TBL] [Abstract][Full Text] [Related]
12. Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of gamma-tocotrienol in neoplastic mammary epithelial cells.
Sylvester PW; Shah SJ; Samant GV
J Plant Physiol; 2005 Jul; 162(7):803-10. PubMed ID: 16008108
[TBL] [Abstract][Full Text] [Related]
13. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.
Tiwari RV; Parajuli P; Sylvester PW
Mol Cell Biochem; 2015 Oct; 408(1-2):123-37. PubMed ID: 26112904
[TBL] [Abstract][Full Text] [Related]
14. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
Wali VB; Bachawal SV; Sylvester PW
Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
[TBL] [Abstract][Full Text] [Related]
16. Role of Rac1/WAVE2 Signaling in Mediating the Inhibitory Effects of γ-Tocotrienol on Mammary Cancer Cell Migration and Invasion.
Algayadh IG; Dronamraju V; Sylvester PW
Biol Pharm Bull; 2016; 39(12):1974-1982. PubMed ID: 27904039
[TBL] [Abstract][Full Text] [Related]
17. Tocotrienols target PI3K/Akt signaling in anti-breast cancer therapy.
Sylvester PW; Ayoub NM
Anticancer Agents Med Chem; 2013 Sep; 13(7):1039-47. PubMed ID: 23272909
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells.
Wali VB; Bachawal SV; Sylvester PW
Apoptosis; 2009 Nov; 14(11):1366-77. PubMed ID: 19771520
[TBL] [Abstract][Full Text] [Related]
19. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
Bachawal SV; Wali VB; Sylvester PW
BMC Cancer; 2010 Mar; 10():84. PubMed ID: 20211018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]